Clinical Trials

For more information regarding our trials, please call our Patient Coordinator

Stephanie Parker | 866.932.8588 | E-Mail

Ovarian Cancers

A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine Encoding the Amino Acids 1-163 of Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) in Patients with Advanced Ovarian Cancer (OC)
Scientific Description   |    Clinical Description

Page last updated 03/01/2012